Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through ...

Medscape Medical News, August 08, 2023 Study Questions Use of Branded Inhalers for COPD Researchers said their analysis found that a generic product approved in 2019 was equally effective as the ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... disease (COPD). Sales of Breztri ...

AstraZeneca may mount a challenge to GlaxoSmithKline’s three-in-one inhaler for chronic obstructive pulmonary disease (COPD) after a late-stage trial success. AZ’s single inhaler, PT010 ...

With COPD, you have lung damage that worsens over time. Trelegy Ellipta does not come as a generic drug. Trelegy Ellipta comes in a dry powder inhaler. Each active ingredient in Trelegy Ellipta ...

awareness of the consequences of generic prescribing of inhalers and specific examples of problems which have arisen. Interviews with community pharmacists will provide data about dispensing ...

Early identification and treatment of patients with COPD at risk of exacerbation are crucial for better outcomes. Single-inhaler triple therapy (SITT) users showed improved exacerbation rates and ...